{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:39:27Z","timestamp":1793317167995,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-210","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T01:01:18Z","timestamp":1410397278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-\u03b1-induced apoptosis"],"prefix":"10.1186","volume":"13","author":[{"given":"Sahana","family":"Holla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devram Sampat","family":"Ghorpade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushagra","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kithiganahalli Narayanaswamy","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,11]]},"reference":[{"key":"1415_CR1","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1128\/iai.64.4.1400-1406.1996","volume":"64","author":"LE Bermudez","year":"1996","unstructured":"Bermudez LE, Goodman J: Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun. 1996, 64: 1400-1406.","journal-title":"Infect Immun"},{"key":"1415_CR2","first-page":"791392","volume":"2012","author":"Y Li","year":"2012","unstructured":"Li Y, Wang Y, Liu X: The role of airway epithelial cells in response to mycobacteria infection. Clin Dev Immunol. 2012, 2012: 791392-","journal-title":"Clin Dev Immunol"},{"key":"1415_CR3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/IAI.66.3.1121-1126.1998","volume":"66","author":"Y Lin","year":"1998","unstructured":"Lin Y, Zhang M, Barnes PF: Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun. 1998, 66: 1121-1126.","journal-title":"Infect Immun"},{"key":"1415_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","volume":"19","author":"JL Flynn","year":"2001","unstructured":"Flynn JL, Chan J: Immunology of tuberculosis. Annu Rev Immunol. 2001, 19: 93-129. 10.1146\/annurev.immunol.19.1.93","journal-title":"Annu Rev Immunol"},{"key":"1415_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper AM: Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009, 27: 393-422. 10.1146\/annurev.immunol.021908.132703","journal-title":"Annu Rev Immunol"},{"key":"1415_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1470-2045(03)01141-0","volume":"4","author":"AM Eggermont","year":"2003","unstructured":"Eggermont AM, de Wilt JH, ten Hagen TL: Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol. 2003, 4: 429-437. 10.1016\/S1470-2045(03)01141-0","journal-title":"Lancet Oncol"},{"key":"1415_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/cncr.21547","volume":"106","author":"DJ Grunhagen","year":"2006","unstructured":"Grunhagen DJ, de Wilt JH, Graveland WJ, van Geel AN, Eggermont AM: The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma. Cancer. 2006, 106: 156-162. 10.1002\/cncr.21547","journal-title":"Cancer"},{"key":"1415_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/JTO.0b013e3181fb4fcc","volume":"6","author":"YH Yu","year":"2011","unstructured":"Yu YH, Liao CC, Hsu WH, Chen HJ, Liao WC, Muo CH, Sung FC, Chen CY: Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol. 2011, 6: 32-37. 10.1097\/JTO.0b013e3181fb4fcc","journal-title":"J Thorac Oncol"},{"key":"1415_CR9","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/ijc.24636","volume":"125","author":"HY Liang","year":"2009","unstructured":"Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS: Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer. 2009, 125: 2936-2944. 10.1002\/ijc.24636","journal-title":"Int J Cancer"},{"key":"1415_CR10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/444545","volume":"192","author":"K Dheda","year":"2005","unstructured":"Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA: Lung remodeling in pulmonary tuberculosis. J Infect Dis. 2005, 192: 1201-1209. 10.1086\/444545","journal-title":"J Infect Dis"},{"key":"1415_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z: Inflammation and cancer. Nature. 2002, 420: 860-867. 10.1038\/nature01322","journal-title":"Nature"},{"key":"1415_CR12","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman JS, Lowe SW: Control of apoptosis by p53. Oncogene. 2003, 22: 9030-9040. 10.1038\/sj.onc.1207116","journal-title":"Oncogene"},{"key":"1415_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature03098","volume":"432","author":"SW Lowe","year":"2004","unstructured":"Lowe SW, Cepero E, Evan G: Intrinsic tumour suppression. Nature. 2004, 432: 307-315. 10.1038\/nature03098","journal-title":"Nature"},{"key":"1415_CR14","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1038\/ncb1202-e275","volume":"4","author":"E de Stanchina","year":"2002","unstructured":"de Stanchina E, Lowe SW: Tumour suppression: something for nothing?. Nat Cell Biol. 2002, 4: E275-E276. 10.1038\/ncb1202-e275","journal-title":"Nat Cell Biol"},{"key":"1415_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature02514","volume":"429","author":"D Dornan","year":"2004","unstructured":"Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM: The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004, 429: 86-92. 10.1038\/nature02514","journal-title":"Nature"},{"key":"1415_CR16","doi-asserted-by":"crossref","first-page":"20067","DOI":"10.1016\/S0021-9258(17)32128-2","volume":"269","author":"H Wu","year":"1994","unstructured":"Wu H, Lozano G: NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem. 1994, 269: 20067-20074.","journal-title":"J Biol Chem"},{"key":"1415_CR17","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1101\/gad.1693608","volume":"22","author":"M Varjosalo","year":"2008","unstructured":"Varjosalo M, Taipale J: Hedgehog: functions and mechanisms. Genes Dev. 2008, 22: 2454-2472. 10.1101\/gad.1693608","journal-title":"Genes Dev"},{"key":"1415_CR18","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","volume":"16","author":"AA Merchant","year":"2010","unstructured":"Merchant AA, Matsui W: Targeting Hedgehog\u2013a cancer stem cell pathway. Clin Cancer Res. 2010, 16: 3130-3140. 10.1158\/1078-0432.CCR-09-2846","journal-title":"Clin Cancer Res"},{"key":"1415_CR19","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham PW, McMahon AP: Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15: 3059-3087. 10.1101\/gad.938601","journal-title":"Genes Dev"},{"key":"1415_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/path.2784","volume":"223","author":"AM Goh","year":"2011","unstructured":"Goh AM, Coffill CR, Lane DP: The role of mutant p53 in human cancer. J Pathol. 2011, 223: 116-126. 10.1002\/path.2784","journal-title":"J Pathol"},{"key":"1415_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1634\/theoncologist.11-4-397","volume":"11","author":"R van Horssen","year":"2006","unstructured":"van Horssen R, Ten Hagen TL, Eggermont AM: TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist. 2006, 11: 397-408. 10.1634\/theoncologist.11-4-397","journal-title":"Oncologist"},{"key":"1415_CR22","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1073\/pnas.0712216105","volume":"105","author":"Y Abe","year":"2008","unstructured":"Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, Okamoto K, Oren M, Tanaka N: Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc Natl Acad Sci U S A. 2008, 105: 4838-4843. 10.1073\/pnas.0712216105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1415_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/MCB.01108-12","volume":"33","author":"DS Ghorpade","year":"2013","unstructured":"Ghorpade DS, Holla S, Kaveri SV, Bayry J, Patil SA, Balaji KN: Sonic hedgehog-dependent induction of microRNA 31 and microRNA 150 regulates Mycobacterium bovis BCG-driven toll-like receptor 2 signaling. Mol Cell Biol. 2013, 33: 543-556. 10.1128\/MCB.01108-12","journal-title":"Mol Cell Biol"},{"key":"1415_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4161\/auto.27225","volume":"10","author":"S Holla","year":"2014","unstructured":"Holla S, Kurowska-Stolarska M, Bayry J, Balaji KN: Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-responsive WNT5A and SHH signaling. Autophagy. 2014, 10: 311-330. 10.4161\/auto.27225","journal-title":"Autophagy"},{"key":"1415_CR25","first-page":"611","volume":"19","author":"DN Mitropoulos","year":"2005","unstructured":"Mitropoulos DN: Novel insights into the mechanism of action of intravesical immunomodulators. In Vivo. 2005, 19: 611-621.","journal-title":"In Vivo"},{"key":"1415_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.eururo.2012.08.055","volume":"62","author":"DR Yates","year":"2012","unstructured":"Yates DR, Brausi MA, Catto JW, Dalbagni G, Roupret M, Shariat SF, Sylvester RJ, Witjes JA, Zlotta AR, Palou-Redorta J: Treatment options available for bacillus Calmette-Guerin failure in non-muscle-invasive bladder cancer. Eur Urol. 2012, 62: 1088-1096. 10.1016\/j.eururo.2012.08.055","journal-title":"Eur Urol"},{"key":"1415_CR27","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1158\/0008-5472.CAN-09-1114","volume":"69","author":"DA Zaharoff","year":"2009","unstructured":"Zaharoff DA, Hoffman BS, Hooper HB, Benjamin CJ, Khurana KK, Hance KW, Rogers CJ, Pinto PA, Schlom J, Greiner JW: Intravesical immunotherapy of superficial bladder cancer with chitosan\/interleukin-12. Cancer Res. 2009, 69: 6192-6199. 10.1158\/0008-5472.CAN-09-1114","journal-title":"Cancer Res"},{"key":"1415_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1513\/pats.200806-048LC","volume":"6","author":"EA Hirschowitz","year":"2009","unstructured":"Hirschowitz EA, Yannelli JR: Immunotherapy for lung cancer. Proc Am Thorac Soc. 2009, 6: 224-232. 10.1513\/pats.200806-048LC","journal-title":"Proc Am Thorac Soc"},{"key":"1415_CR29","first-page":"237","volume":"2","author":"S Murala","year":"2010","unstructured":"Murala S, Alli V, Kreisel D, Gelman AE, Krupnick AS: Current status of immunotherapy for the treatment of lung cancer. J Thorac Dis. 2010, 2: 237-244.","journal-title":"J Thorac Dis"},{"key":"1415_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1586\/14760584.4.3.329","volume":"4","author":"S Mosolits","year":"2005","unstructured":"Mosolits S, Nilsson B, Mellstedt H: Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Rev Vaccines. 2005, 4: 329-350. 10.1586\/14760584.4.3.329","journal-title":"Expert Rev Vaccines"},{"key":"1415_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(73)90526-6","volume":"1","author":"JU Gutterman","year":"1973","unstructured":"Gutterman JU, Mavligit G, McBride C, Frei E, Freireich EJ, Hersh EM: Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet. 1973, 1: 1208-1212.","journal-title":"Lancet"},{"key":"1415_CR32","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1586\/era.11.163","volume":"11","author":"JH Stewart","year":"2011","unstructured":"Stewart JH, Levine EA: Role of bacillus Calmette-Guerin in the treatment of advanced melanoma. Expert Rev Anticancer Ther. 2011, 11: 1671-1676. 10.1586\/era.11.163","journal-title":"Expert Rev Anticancer Ther"},{"key":"1415_CR33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.57187\/smw.2007.11077","volume":"137","author":"LH Butterfield","year":"2007","unstructured":"Butterfield LH: Recent advances in immunotherapy for hepatocellular cancer. Swiss Med Wkly. 2007, 137: 83-90.","journal-title":"Swiss Med Wkly"},{"key":"1415_CR34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3892\/etm.2012.855","volume":"5","author":"X Lu","year":"2013","unstructured":"Lu X, Wu L, Liu Z, Xie L, Wang S: Peripheral blood mononuclear cells inhibit proliferation and promote apoptosis of HeLa cells following stimulation with Bacillus Calmette-Guerin. Exp Ther Med. 2013, 5: 561-566.","journal-title":"Exp Ther Med"},{"key":"1415_CR35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1086\/340040","volume":"185","author":"K Sato","year":"2002","unstructured":"Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C: Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J Infect Dis. 2002, 185: 1139-1147. 10.1086\/340040","journal-title":"J Infect Dis"},{"key":"1415_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP: Cancer. p53, guardian of the genome. Nature. 1992, 358: 15-16. 10.1038\/358015a0","journal-title":"Nature"},{"key":"1415_CR37","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993, 74: 957-967. 10.1016\/0092-8674(93)90719-7","journal-title":"Cell"},{"key":"1415_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrc3271","volume":"12","author":"JC Marine","year":"2012","unstructured":"Marine JC: Spotlight on the role of COP1 in tumorigenesis. Nat Rev Cancer. 2012, 12: 455-464. 10.1038\/nrc3271","journal-title":"Nat Rev Cancer"},{"key":"1415_CR39","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1200\/JCO.2005.23.648","volume":"23","author":"AA Adjei","year":"2005","unstructured":"Adjei AA, Hidalgo M: Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol. 2005, 23: 5386-5403. 10.1200\/JCO.2005.23.648","journal-title":"J Clin Oncol"},{"key":"1415_CR40","doi-asserted-by":"publisher","first-page":"12501","DOI":"10.1074\/jbc.M709960200","volume":"283","author":"Y Narayana","year":"2008","unstructured":"Narayana Y, Balaji KN: NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 expression in macrophages. J Biol Chem. 2008, 283: 12501-12511. 10.1074\/jbc.M709960200","journal-title":"J Biol Chem"},{"key":"1415_CR41","doi-asserted-by":"publisher","first-page":"37032","DOI":"10.1074\/jbc.M111.260414","volume":"286","author":"K Bansal","year":"2011","unstructured":"Bansal K, Trinath J, Chakravortty D, Patil SA, Balaji KN: Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling. J Biol Chem. 2011, 286: 37032-37044. 10.1074\/jbc.M111.260414","journal-title":"J Biol Chem"},{"key":"1415_CR42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW: Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976, 116: 180-183.","journal-title":"J Urol"},{"key":"1415_CR43","first-page":"281","volume":"10","author":"HB Grossman","year":"2008","unstructured":"Grossman HB, O'Donnell MA, Cookson MS, Greenberg RE, Keane TE: Bacillus calmette-guerin failures and beyond: contemporary management of non-muscle-invasive bladder cancer. Rev Urol. 2008, 10: 281-289.","journal-title":"Rev Urol"},{"key":"1415_CR44","first-page":"15","volume":"2008","author":"W Cai","year":"2008","unstructured":"Cai W, Kerner ZJ, Hong H, Sun J: Targeted cancer therapy with tumor necrosis factor-alpha. Biochem Insights. 2008, 2008: 15-21.","journal-title":"Biochem Insights"},{"key":"1415_CR45","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1189\/jlb.0703313","volume":"76","author":"A Martino","year":"2004","unstructured":"Martino A, Sacchi A, Sanarico N, Spadaro F, Ramoni C, Ciaramella A, Pucillo LP, Colizzi V, Vendetti S: Dendritic cells derived from BCG-infected precursors induce Th2-like immune response. J Leukoc Biol. 2004, 76: 827-834. 10.1189\/jlb.0703313","journal-title":"J Leukoc Biol"},{"key":"1415_CR46","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1084\/jem.20062105","volume":"204","author":"JP Scott-Browne","year":"2007","unstructured":"Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, Bevan MJ, Urdahl KB: Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med. 2007, 204: 2159-2169. 10.1084\/jem.20062105","journal-title":"J Exp Med"},{"key":"1415_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0065-230X(10)07003-X","volume":"107","author":"D Mougiakakos","year":"2010","unstructured":"Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC: Regulatory T cells in cancer. Adv Cancer Res. 2010, 107: 57-117.","journal-title":"Adv Cancer Res"},{"key":"1415_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4161\/onci.1.1.17939","volume":"1","author":"MP Protti","year":"2012","unstructured":"Protti MP, De Monte L: Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer. Oncoimmunology. 2012, 1: 89-91. 10.4161\/onci.1.1.17939","journal-title":"Oncoimmunology"},{"key":"1415_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1365-2249.1995.tb03599.x","volume":"100","author":"JS Shin","year":"1995","unstructured":"Shin JS, Park JH, Kim JD, Lee JM, Kim SJ: Induction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guerin. Clin Exp Immunol. 1995, 100: 26-31.","journal-title":"Clin Exp Immunol"},{"key":"1415_CR50","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","volume":"22","author":"S Wang","year":"2003","unstructured":"Wang S, El-Deiry WS: TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 2003, 22: 8628-8633. 10.1038\/sj.onc.1207232","journal-title":"Oncogene"},{"key":"1415_CR51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1128\/IAI.71.1.254-259.2003","volume":"71","author":"CJ Riendeau","year":"2003","unstructured":"Riendeau CJ, Kornfeld H: THP-1 cell apoptosis in response to Mycobacterial infection. Infect Immun. 2003, 71: 254-259. 10.1128\/IAI.71.1.254-259.2003","journal-title":"Infect Immun"},{"key":"1415_CR52","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.4049\/jimmunol.176.7.4267","volume":"176","author":"J Lee","year":"2006","unstructured":"Lee J, Remold HG, Ieong MH, Kornfeld H: Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol. 2006, 176: 4267-4274. 10.4049\/jimmunol.176.7.4267","journal-title":"J Immunol"},{"key":"1415_CR53","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1128\/MCB.06597-11","volume":"32","author":"DS Ghorpade","year":"2012","unstructured":"Ghorpade DS, Leyland R, Kurowska-Stolarska M, Patil SA, Balaji KN: MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages. Mol Cell Biol. 2012, 32: 2239-2253. 10.1128\/MCB.06597-11","journal-title":"Mol Cell Biol"},{"key":"1415_CR54","doi-asserted-by":"publisher","first-page":"52093","DOI":"10.1074\/jbc.M305624200","volume":"278","author":"N Wajapeyee","year":"2003","unstructured":"Wajapeyee N, Somasundaram K: Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1\/CIP1 in AP-2alpha-mediated growth inhibition. J Biol Chem. 2003, 278: 52093-52101. 10.1074\/jbc.M305624200","journal-title":"J Biol Chem"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T13:53:06Z","timestamp":1689515586000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-210","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,11]]},"assertion":[{"value":"30 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"210"}}